A group of 30 public and private bodies has launched a €196-million drug discovery project based on a shared collection of potential medical compounds.
The five-year project, called the European Lead Factory, was launched on 7 February. It includes the creation of a Joint European Compound Collection and the setup of a European Screening Centre, based in the Netherlands and the UK.
In drug discovery, a lead compound is a chemical compound whose pharmacological or biological activity can be used as a starting point to design a medicine.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.